Physician Wealth Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Physician Wealth Advisors's CRL Position: Q3 2026 in Review
Physician Wealth Advisors increased its Charles River Laboratories (CRL) stake by 9.3% in Q3 2026, buying an estimated $1.05K and bringing the position to 47 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #811.
Physician Wealth Advisors first reported a position in CRL in Q1 2025 and has held it in 7 quarters since. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Physician Wealth Advisors held 47 shares of Charles River Laboratories worth $13.9K as of Q3 2026.
- Physician Wealth Advisors bought 4 Charles River Laboratories shares in Q3 2026, an estimated $1.05K.
- Charles River Laboratories made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #811 holding.
- Physician Wealth Advisors first reported a position in Charles River Laboratories in Q1 2025 and has held it in 7 quarters since.
- 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.